Pitney Bowes [PBI] vs Cryoport [CYRX] Detailed Stock Comparison

Pitney Bowes

NYSE
Loading...

Cryoport

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Pitney Bowes wins in 14 metrics, Cryoport wins in 4 metrics, with 0 ties. Pitney Bowes appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Pitney Bowes Cryoport Better
P/E Ratio (TTM) 13.76 -4.02 Cryoport
Price-to-Book Ratio -3.73 1.03 Pitney Bowes
Debt-to-Equity Ratio -3.77 44.34 Pitney Bowes
PEG Ratio -0.06 0.02 Pitney Bowes
EV/EBITDA 9.62 -13.76 Cryoport
Profit Margin (TTM) -5.60% 31.67% Cryoport
Operating Margin (TTM) 15.47% -21.23% Pitney Bowes
EBITDA Margin (TTM) 15.47% N/A N/A
Return on Equity 35.20% -9.19% Pitney Bowes
Return on Assets (TTM) 4.47% -4.21% Pitney Bowes
Free Cash Flow (TTM) $156.77M $-37.59M Pitney Bowes
Dividend Yield 1.54% N/A N/A
1-Year Return 61.71% 42.41% Pitney Bowes
Price-to-Sales Ratio (TTM) 0.96 2.10 Pitney Bowes
Enterprise Value $3.62B $331.48M Pitney Bowes
EV/Revenue Ratio 1.84 1.39 Cryoport
Gross Profit Margin (TTM) 53.59% 47.03% Pitney Bowes
Revenue per Share (TTM) $11 $5 Pitney Bowes
Earnings per Share (Diluted) $0.80 $-1.00 Pitney Bowes
Beta (Stock Volatility) 1.26 1.61 Pitney Bowes
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Pitney Bowes vs Cryoport Stock Performance Analysis

Loading Price Chart...

Pitney Bowes
Cryoport
Pitney Bowes Stock Overview | Cryoport Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Pitney Bowes-5.12%2.31%-1.79%5.59%35.81%59.70%
Cryoport-6.44%6.20%0.91%32.71%85.45%24.56%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Pitney Bowes61.71%310.32%89.02%-44.57%-47.26%-72.29%
Cryoport42.41%-58.84%-78.67%279.39%4.85%-98.67%

News Based Sentiment: Pitney Bowes vs Cryoport

Pitney Bowes

News based Sentiment: MIXED

The month featured a significant leadership change with the election of a new Board Chair, but this was coupled with a downward revision of revenue guidance. While the leadership change is positive, the reduced outlook creates uncertainty, resulting in a mixed overall investment story.

View Pitney Bowes News Sentiment Analysis

Cryoport

News based Sentiment: MIXED

Cryoport is making strategic moves to expand its global footprint, but its recent financial performance is mixed, with negative revenue growth and profitability concerns. Insider selling adds another layer of complexity, creating a balanced investment narrative.

View Cryoport News Sentiment Analysis

Performance & Financial Health Analysis: Pitney Bowes vs Cryoport

MetricPBICYRX
Market Information
Market Cap i$1.94B$490.66M
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i2,468,800497,290
90 Day Avg. Volume i2,877,707593,737
Last Close$10.94$9.30
52 Week Range$6.66 - $13.11$4.58 - $10.46
% from 52W High-16.55%-11.09%
All-Time High$73.31 (Apr 26, 1999)$768.00 (Nov 21, 2005)
% from All-Time High-85.08%-98.79%
Growth Metrics
Quarterly Revenue Growth-0.06%0.15%
Quarterly Earnings Growth-0.42%-0.21%
Financial Health
Profit Margin (TTM) i-0.06%0.32%
Operating Margin (TTM) i0.15%-0.21%
Return on Equity (TTM) i0.35%-0.09%
Debt to Equity (MRQ) i-3.7744.34
Cash & Liquidity
Book Value per Share (MRQ)$-3.06$9.49
Cash per Share (MRQ)$1.75$8.51
Operating Cash Flow (TTM) i$243.93M$-16,720,000
Levered Free Cash Flow (TTM) i$229.59M$-11,699,250
Dividends
Last 12-Month Dividend Yield i1.54%N/A
Last 12-Month Dividend i$0.16N/A

Valuation & Enterprise Metrics Analysis: Pitney Bowes vs Cryoport

MetricPBICYRX
Price Ratios
P/E Ratio (TTM) i13.76-4.02
Forward P/E i11.01-10.10
PEG Ratio i-0.060.02
Price to Sales (TTM) i0.962.10
Price to Book (MRQ) i-3.731.03
Market Capitalization
Market Capitalization i$1.94B$490.66M
Enterprise Value i$3.62B$331.48M
Enterprise Value Metrics
Enterprise to Revenue i1.841.39
Enterprise to EBITDA i9.62-13.76
Risk & Other Metrics
Beta i1.261.61
Book Value per Share (MRQ) i$-3.06$9.49

Financial Statements Comparison: Pitney Bowes vs Cryoport

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)PBICYRX
Revenue/Sales i$493.42M$41.04M
Cost of Goods Sold i$224.30M$22.40M
Gross Profit i$269.12M$18.64M
Research & Development i$4.76M$3.93M
Operating Income (EBIT) i$96.59M$-9.48M
EBITDA i$100.73M$-2.14M
Pre-Tax Income i$46.73M$-8.79M
Income Tax i$11.31M$234,000
Net Income (Profit) i$35.42M$-11.98M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)PBICYRX
Cash & Equivalents i$323.79M$36.10M
Total Current Assets i$1.18B$411.28M
Total Current Liabilities i$1.49B$74.03M
Long-Term Debt i$2.00B$224.19M
Total Shareholders Equity i$-535.88M$398.81M
Retained Earnings i$2.65B$-769.16M
Property, Plant & Equipment i$342.09M$119.58M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)PBICYRX
Operating Cash Flow i$94.41M$-6.40M
Capital Expenditures iN/A$-3.17M
Free Cash Flow i$-33.57M$-8.42M
Debt Repayment i$-787.19M$-192,000
Common Stock Repurchase i$-15.00MN/A

Short Interest & Institutional Ownership Analysis

MetricPBICYRX
Shares Short i20.57M2.52M
Short Ratio i6.604.33
Short % of Float i0.15%0.06%
Average Daily Volume (10 Day) i2,468,800497,290
Average Daily Volume (90 Day) i2,877,707593,737
Shares Outstanding i182.41M49.91M
Float Shares i157.71M40.88M
% Held by Insiders i0.01%0.04%
% Held by Institutions i0.76%1.02%

Dividend Analysis & Yield Comparison: Pitney Bowes vs Cryoport

MetricPBICYRX
Last 12-Month Dividend i$0.16N/A
Last 12-Month Dividend Yield i1.54%N/A
3-Year Avg Annual Dividend i$0.17N/A
3-Year Avg Dividend Yield i1.10%N/A
3-Year Total Dividends i$0.51N/A
Ex-Dividend DateFeb 21, 2025N/A